BioSpace News Archive

According to Precedence Research, The generic sterile injectable market size is expected to be worth around US$ 84.85 billion by 2030, growing at a CAGR of 10.3% over the forecast period 2022 to 2030.

The healthcare facilities management market size is expected to hit US$ 473.18 bn by 2027 and poised to grow at a CAGR of 13.2% during the forecast period 2021 to 2027, according to Precedence Research.

The single-use bioprocessing market size is expected to hit US$ 84.12 billion by 2030 from valued at US$ 21.98 billion in 2021 and growing at a CAGR of 16.1% from 2022 to 2030.

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced new findings by Daniel Snellings from the lab of Douglas Marchuk, PhD, at Duke University School of Medicine using single-cell DNA sequencing to identify genetic mechanisms leading to the development of cerebral cavernous malformations (CCMs).

Adlai Nortye Ltd., a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, is pleased to welcome new senior level talent to its dynamic global leadership team.

Biovica, active in cancer diagnostics, announces that the company will establish its own US CLIA lab for the launch of DiviTum®TKa on the US market.

I Peace, Inc., a Palo Alto-based biotech start-up, announced that the company had tripled its capacity to manufacture GMP grade iPS cells and iPSC-derived differentiated cells by expanding its facility.

Akoya Biosciences, Inc., The Spatial Biology Company®, announced its financial results for the fourth quarter and full year ending December 31, 2021.

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that John Bagdasarian has joined the company as Vice President of Professional Relations.

Viridian Therapeutics, Inc. announced that Jonathan Violin, Ph.D., President and Chief Executive Officer of Viridian, will participate in a fireside chat at the 32nd Annual Oppenheimer Healthcare Conference on March 15, 2022.